SCHEMBL17876301

SCHEMBL17876301

c1ccc(N2Cc3ccc(-c4ccc5oc6ccccc6c5c4)cc3-c3cc(-c4ccc5oc6ccccc6c5c4)ccc3C2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 2/20 0.40
HPGD P15428 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 2/20 0.40
PRKDC P78527 3/20 0.39
PLA2G2A P14555 3/20 0.38
PLA2G4A P47712 3/20 0.38
HCRTR1 O43613 1/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PLA2G10 O15496 1/20 0.36
AHR P35869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876300 0.96 NPC1 (0.39) MAPTNPC1RAB9AKDM4EMEN1
SCHEMBL17876303 0.95 PRKDC (0.42) MAPTNPC1RAB9AKDM4EMEN1
SCHEMBL17876243 0.95 MAPT (0.36) MAPTNPC1RAB9AKDM4EMEN1
SCHEMBL17876293 0.92 NPC1 (0.41) MAPTNPC1RAB9AKDM4EMEN1
SCHEMBL17876305 0.92 PRKDC (0.36) MAPTNPC1RAB9AKDM4EMEN1
SCHEMBL17876247 0.92 NPC1 (0.36) MAPTNPC1RAB9AKDM4EMEN1
SCHEMBL17876260 0.91 PRKDC (0.39) MAPTNPC1RAB9AKDM4EMEN1
SCHEMBL17876290 0.91 ALOX5 (0.48) MAPTKDM4EMEN1HPGDKMT2A
SCHEMBL17876248 0.91 PRKDC (0.39) MAPTNPC1RAB9AKDM4EMEN1
SCHEMBL17876285 0.90 KDM4E (0.36) MAPTNPC1RAB9AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 MAPT 2144/4885NPC1 2673/4885RAB9A 2843/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MAPT 2144/4885NPC1 2673/4885RAB9A 2843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.